Amneal launches generic OTC Narcan Nasal Spray

Amneal is offering OTC Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, 4 mg, which is the generic of Emergent Operations Ireland’s OTC Narcan HCI Nasal Spray. 

The medication that is widely used to help treat drug overdose from opioids, including heroin, fentanyl and prescription opioid medications.

“With today’s launch, Amneal is proud to help address this public health emergency by providing naloxone nasal spray at an affordable price and without a prescription. Our business is deeply rooted in a commitment to helping others. By enhancing access to naloxone nasal spray, we hope to get this affordable emergency treatment into the hands of even more people who could potentially save countless families and communities from further heartache and loss,” said Chirag and Chintu Patel, co-CEOs.

Amneal noted that more than two-thirds of all drug overdose fatalities in 2022 involved illicit, synthetic opioids like fentanyl, which is the culprit in more deaths under age 50 than any other cause, including heart disease, cancer, homicide, suicide and other accidents. According to the Centers for Disease Control and Prevention, in about 46% of overdose deaths, another person is present and has the potential to intervene, the company said.

[Read more: Amneal debuts 2 generics]

Narcan Naloxone HCl Nasal Spray 4mg had a market value of $266 million for the 12 months ended February 2024, per IQVIA. In addition, there are significant volumes of the product acquired directly by U.S. states and municipalities.